Tsuyoshi Fujita to Lipopolysaccharides
This is a "connection" page, showing publications Tsuyoshi Fujita has written about Lipopolysaccharides.
Connection Strength
0.047
-
Nishida M, Nishiumi S, Mizushina Y, Fujishima Y, Yamamoto K, Masuda A, Mizuno S, Fujita T, Morita Y, Kutsumi H, Yoshida H, Azuma T, Yoshida M. Monoacetylcurcumin strongly regulates inflammatory responses through inhibition of NF-kappaB activation. Int J Mol Med. 2010 May; 25(5):761-7.
Score: 0.018
-
Kure I, Nishiumi S, Nishitani Y, Tanoue T, Ishida T, Mizuno M, Fujita T, Kutsumi H, Arita M, Azuma T, Yoshida M. Lipoxin A(4) reduces lipopolysaccharide-induced inflammation in macrophages and intestinal epithelial cells through inhibition of nuclear factor-kappaB activation. J Pharmacol Exp Ther. 2010 Feb; 332(2):541-8.
Score: 0.018
-
Hashimoto M, Kirikae F, Dohi T, Adachi S, Kusumoto S, Suda Y, Fujita T, Naoki H, Kirikae T. Structural study on lipid A and the O-specific polysaccharide of the lipopolysaccharide from a clinical isolate of Bacteroides vulgatus from a patient with Crohn's disease. Eur J Biochem. 2002 Aug; 269(15):3715-21.
Score: 0.011